Active

Epidarex Capital

General contacts

Investor type

VC / PE

Founded

2010

AUM

$395 M

Location

Bethesda, Maryland, United States

Investment Ticket

$50-100 m

Investment Stage

Series A Seed Late Stage (Series C+)

Region of investment

North America Europe

Investor profile last updated: 18 August, 2026

Profile

Epidarex Capital is a venture capital firm based in Bethesda, Maryland, founded in 2010. The firm is led by a diverse team of early-stage investors focused on building breakthrough life science companies in emerging hubs. With a team of around 10 professionals, Epidarex leverages deep scientific and industry networks to create exceptional value for its portfolio companies.

Epidarex Capital invests primarily in life sciences, biotechnology, pharmaceuticals, medical devices, and health technology sectors. The firm targets early-stage investments, particularly in Series A rounds, with a focus on companies based in the United States and the United Kingdom. Epidarex manages several funds, including Epidarex Capital II with $47 million AUM and Epidarex Capital III with $105 million AUM.

Notable investments by Epidarex Capital include RapidPulse - stroke aspiration technology, Mironid - therapeutic devices, Leucid Bio - drug discovery, Epsilogen - drug discovery, and Theolytics - drug discovery. These investments highlight the firm's commitment to advancing innovative solutions in the life sciences sector.

Industry

HealthTech Life Sciences Technology MedTech Pharmaceuticals Medical Devices Healthcare Services Biotechnology Financial Services Fintech

Epidarex Capital Funds

Name	Type	Industry	Stage	Region	Size	AUM	Launch date
Epidarex Capital II	Venture Capital (VC)	Financial Services Fintech Healthcare Services HealthTech	Pre-seed Seed	North America Europe	$5-10 m	$47 M	May 2014
Epidarex Capital III	Venture Capital (VC)	Financial Services Fintech Healthcare Services HealthTech	Pre-seed Seed	North America	$5-10 m	$105 M	June 2020
Epidarex Capital IV, LP	Venture Capital (VC)	Financial Services Fintech Healthcare Services HealthTech Medical Devices Life Sciences	Pre-seed Seed Series A	North America Europe	$5-10 m	$110 M	January 2026

Contacts

Name

Title

Social Networks

Kyparissia Sirinakis Co-Founder & Managing Partner

Co-Founder & Managing Partner

k•••@•••

Sinclair Dunlop Managing Partner

Managing Partner

s•••@•••

Upgrade to see contacts

scr8uaXE07FbTD9L scr8uaXE07FbTD9L

scr8uaXE07FbTD9L

[email protected]

scr8uaXE07FbTD9L scr8uaXE07FbTD9L

scr8uaXE07FbTD9L

[email protected]

scr8uaXE07FbTD9L scr8uaXE07FbTD9L

scr8uaXE07FbTD9L

[email protected]

Investment-team contacts for Epidarex Capital — including verified work emails and LinkedIn profiles — are available to Private Equity List subscribers.
Instant access on the web. Plans from $129/month — see pricing.

Contacts sourced from the firm's website and LinkedIn, re-verified on a rolling cycle. Spot a stale contact, or none at all? Report it — we re-run that firm within 48h and get back to you.

FAQs about Epidarex Capital

Is Epidarex Capital a venture capital or private equity firm?

Epidarex Capital is a venture capital and private equity firm. It backs companies at Series A, Seed and Late Stage (Series C+), writing tickets of $50-100 m.

Where is Epidarex Capital located?

Epidarex Capital is located in Bethesda, Maryland, United States.

When was Epidarex Capital founded?

Epidarex Capital was founded in 2010.

What sectors and industries does Epidarex Capital invest in?

Epidarex Capital invests in companies and startups in HealthTech, Life Sciences, Technology, MedTech, Pharmaceuticals, Medical Devices, Healthcare Services, Biotechnology, Financial Services, Fintech.

What is Epidarex Capital geographical focus of investments?

Epidarex Capital invests in companies and startups in North America, Europe.

At what stages of companies and startups does Epidarex Capital typically invest in?

Epidarex Capital invests in companies and startups at Series A, Seed, Late Stage (Series C+).

What is the usual amount of Epidarex Capital investment?

Epidarex Capital usually invests $50-100 m on average.

What is the amount of assets of under management (AUM) for Epidarex Capital?

Epidarex Capital has around $395m assets under management.

When was Epidarex Capital last fund created?

Epidarex Capital last fund was created/launched in 2026-01-27

What are the contacts of Epidarex Capital?

Epidarex Capital can be reached through its website epidarex.com, its LinkedIn page and its X account. Its general enquiries address is [email protected]. Cold-mailing a general inbox rarely reaches a partner, so Private Equity List also lists the investment-team contacts for Epidarex Capital — names, roles, verified work emails and LinkedIn profiles — available on a Pro plan from $129/month (see pricing). Contacts are sourced from the firm's website and LinkedIn and re-verified on a rolling cycle. Spot a stale contact, or none at all? Report it — we re-run that firm within 48h and get back to you.

Can I access Epidarex Capital data via API or MCP?

Yes. Every field on this page — profile, funds, investment criteria, portfolio and investment-team contacts — is available programmatically through the Private Equity List REST API and MCP server, so AI assistants such as Claude and ChatGPT can query Epidarex Capital directly instead of scraping this page. One subscription covers both the web app and machine access — see API & MCP.

When was the Epidarex Capital profile last updated?

Private Equity List re-verifies investor profiles on a rolling cycle, pulling from the firm's own website and LinkedIn rather than a one-off import. This profile was last updated on 18 August, 2026. Something out of date here? Report it — we re-run that firm within 48h and get back to you.